ASTRAZENECA PHARMA INDIA
Back to Income Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,296 Cr | ₹1,003 Cr | ₹806 Cr | ₹814 Cr | ₹832 Cr |
What is the latest Revenue of ASTRAZENECA PHARMA INDIA ?
Year | Revenue |
---|---|
Mar2024 | ₹1,296 Cr |
Mar2023 | ₹1,003 Cr |
Mar2022 | ₹806 Cr |
Mar2021 | ₹814 Cr |
Mar2020 | ₹832 Cr |
How is Revenue of ASTRAZENECA PHARMA INDIA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,296 Cr | 29.17 | |
Mar2023 | ₹1,003 Cr | 24.50 | |
Mar2022 | ₹806 Cr | -0.98 | |
Mar2021 | ₹814 Cr | -2.19 | |
Mar2020 | ₹832 Cr | - |
Compare Revenue of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹17,324.9 Cr | -0.3% | 8.6% | 8.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹437,135.0 Cr | 2.6% | -1.1% | 38.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹153,074.0 Cr | -3.8% | -1.9% | 60.1% | Stock Analytics | |
CIPLA | ₹114,019.0 Cr | -2.4% | -5.2% | 10.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,192.0 Cr | -5.9% | -9.6% | 14.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,256.3 Cr | -3.9% | -0.3% | 40.6% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | -0.3% |
8.6% |
8.6% |
SENSEX | -0.6% |
-2.9% |
6.3% |
You may also like the below Video Courses